TABLE 3

Outcomes of Infants With NAS According to Sex, TennCare, 2009 to 2011

VariableMale Infants (n = 484)Female Infants (n = 443)P
Newborn health care utilization patterns
 NAS requiring pharmacologic treatmenta309 (63.8)274 (61.9).53
 LOS, median (IQR)10 (5–21)9 (5–19).62
 LOS if pharmacologically treated, median (IQR)17 (10–28)16 (10–29).84
Newborn comorbidities
 Transient tachypnea76 (15.7)46 (10.4).02
 Meconium aspiration syndrome14 (2.9)13 (2.9).97
 Respiratory distress syndrome35 (7.3)22 (5.0).15
 Other respiratory diagnosis78 (16.1)51 (11.5).04
 Jaundice184 (38.0)155 (35.0).34
 Feeding difficulty58 (12.0)61 (13.8).42
 Seizures13 (2.7)15 (3.4).53
 Hemolytic disease11 (2.3)14 (3.2).41
  • Data are presented as n (%) unless otherwise indicated. IQR, interquartile range.

  • a Hospitalization >6 days.